Glucosamine Linked to Higher Alzheimer’s and Dementia Risk, Study Warns

Recent safety signals regarding the widely used supplement glucosamine have drawn urgent scrutiny from medical researchers examining potential long-term risks for patients with mild cognitive impairment. Clinical investigators are now closely evaluating whether chronic supplementation could accelerate neurodegenerative processes in vulnerable populations, prompting a fresh look at standard preventive guidelines for aging adults. The core … Read more

SGLT2 Inhibitors Reduce Alzheimer’s Risk by 43%: New Study Findings

Recent clinical research indicates that patients prescribed SGLT2 inhibitors—a class of medication primarily used to treat type 2 diabetes—may experience a significantly lower risk of developing Alzheimer’s disease. Data suggest that the anti-inflammatory and metabolic benefits of these drugs could play a protective role in neurological health, potentially reducing the incidence of dementia by 43% … Read more

Vitamin D Deficiency at Age 40 Linked to Alzheimer’s Risk 16 Years Later: New Study Warns of Brain Impact

Recent research has highlighted a growing connection between vitamin D levels and long-term brain health, suggesting that maintaining adequate levels of this nutrient in midlife may play a role in reducing the risk of cognitive decline decades later. As populations age globally, understanding modifiable risk factors for neurodegenerative conditions like Alzheimer’s disease has become a … Read more